201 related articles for article (PubMed ID: 37015898)
21. Novel nomogram for predicting survival in advanced non-small cell lung cancer receiving anti-PD-1 plus chemotherapy with or without antiangiogenic therapy.
Wu Y; Lv C; Lin M; Hong Y; Du B; Yao N; Zhu Y; Ji X; Li J; Lai J
Front Immunol; 2023; 14():1297188. PubMed ID: 38022521
[TBL] [Abstract][Full Text] [Related]
22. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
23. Construction and Validation of a Nomogram for Predicting Progression- Free Survival in Patients with Early-Stage Testicular Germ Cell Tumor.
Chen JG; Wang JQ; Peng TW; Chen ZS; Zhao SC
Recent Pat Anticancer Drug Discov; 2021; 16(1):44-53. PubMed ID: 33573563
[TBL] [Abstract][Full Text] [Related]
24. Prognostic nomogram and novel risk-scoring system for small cell lung cancer with different patterns of metastases.
Ruan H; Sun H; Guo Y; Ding Y; Liu Y; Ying S; Lin P
Gen Thorac Cardiovasc Surg; 2022 Dec; 70(12):1022-1031. PubMed ID: 35716296
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological features and prognostic nomogram of giant cell carcinoma of the lung: A population-based study.
He J; Ni JP; Li GB; Yao J; Ni B
Clin Respir J; 2023 Mar; 17(3):197-210. PubMed ID: 36718941
[TBL] [Abstract][Full Text] [Related]
26. Nomograms based on SUVmax of
Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
[TBL] [Abstract][Full Text] [Related]
27. Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms.
Kang J; Ning MS; Feng H; Li H; Bahig H; Brooks ED; Welsh JW; Ye R; Miao H; Chang JY
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):90-99. PubMed ID: 31586665
[TBL] [Abstract][Full Text] [Related]
28. The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer.
Yılmaz A; Tekin SB; Bilici M; Yılmaz H
Lung; 2020 Aug; 198(4):695-704. PubMed ID: 32424800
[TBL] [Abstract][Full Text] [Related]
29. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
30. Identification and validation of serum tumor-markers based nomogram to predict the prognostic value of patients with cervical adenocarcinoma.
Liu Y; Shi L; Chen K; Ye W
Curr Probl Cancer; 2022 Dec; 46(6):100899. PubMed ID: 36270166
[TBL] [Abstract][Full Text] [Related]
31. Development and Validation of a Nomogram Prognostic Model for SCLC Patients.
Wang S; Yang L; Ci B; Maclean M; Gerber DE; Xiao G; Xie Y
J Thorac Oncol; 2018 Sep; 13(9):1338-1348. PubMed ID: 29902534
[TBL] [Abstract][Full Text] [Related]
32. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
33. Clinical usefulness of the lymphocyte-to-monocyte ratio and aggregate index of systemic inflammation in patients with esophageal cancer: a retrospective cohort study.
Wang HK; Wei Q; Yang YL; Lu TY; Yan Y; Wang F
Cancer Cell Int; 2023 Jan; 23(1):13. PubMed ID: 36707809
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of two prognostic nomograms for predicting survival in patients with non-small cell and small cell lung cancer.
Xiao HF; Zhang BH; Liao XZ; Yan SP; Zhu SL; Zhou F; Zhou YK
Oncotarget; 2017 Sep; 8(38):64303-64316. PubMed ID: 28969072
[TBL] [Abstract][Full Text] [Related]
35. A novel LASSO-derived prognostic model predicting survival for non-small cell lung cancer patients with M1a diseases.
Chen H; Huang C; Ge H; Chen Q; Chen J; Li Y; Chen H; Luo S; Zhao L; Xu X
Cancer Med; 2022 Mar; 11(6):1561-1572. PubMed ID: 35128839
[TBL] [Abstract][Full Text] [Related]
36. A prognostic nomogram to predict survival in elderly patients with small-cell lung cancer: a large population-based cohort study and external validation.
Lu G; Li J; Ruan Y; Shi Y; Zhang X; Xia Y; Zhu Z; Lin J; Li L
BMC Cancer; 2022 Dec; 22(1):1271. PubMed ID: 36474197
[TBL] [Abstract][Full Text] [Related]
37. Nomograms Predict PFS and OS for SCLC Patients After Standardized Treatment: A Real-World Study.
Li K; Qiu L; Zhao Y; Sun X; Shao J; He C; Qin B; Jiao S
Int J Gen Med; 2024; 17():1949-1965. PubMed ID: 38736664
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of a prognostic nomogram model incorporating routine laboratory biomarkers for preoperative patients with endometrial cancer.
Cong R; Li M; Xu W; Ma X; Wang S
BMC Cancer; 2023 Nov; 23(1):1167. PubMed ID: 38031022
[TBL] [Abstract][Full Text] [Related]
39. A predictive model based on liquid biopsy for non-small cell lung cancer to assess patient's prognosis: Development and application.
Gu T; Ren J; Hu Z; Wei Y; Huang J
Tissue Cell; 2022 Aug; 77():101854. PubMed ID: 35752028
[TBL] [Abstract][Full Text] [Related]
40. Nomograms and scoring system for forecasting overall and cancer-specific survival of patients with prostate cancer.
Zhou Y; Lin C; Zhu L; Zhang R; Cheng L; Chang Y
Cancer Med; 2023 Feb; 12(3):2600-2613. PubMed ID: 35993499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
